Testing effectiveness (Phase 2)Study completedNCT00079313
What this trial is testing
Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelogenous Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 7